HC Wainwright Has Positive Outlook of RNAZ FY2024 Earnings

TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Free Report) – HC Wainwright boosted their FY2024 earnings estimates for shares of TransCode Therapeutics in a report issued on Wednesday, December 18th. HC Wainwright analyst E. Bodnar now expects that the company will post earnings per share of ($4.76) for the year, up from their previous estimate of ($60.73). […]

Leave a Reply

Your email address will not be published.

Previous post KeyCorp Weighs in on Global Payments FY2024 Earnings
Next post Wedbush Issues Positive Outlook for Texas Roadhouse Earnings